Medeon Competitors

Stocks . Taiwan . 
Stock . Medeon Biodesign
6499 Stock  TWD 42.50  1.15  2.63%   
Medeon Biodesign competes with Hotel Holiday, First Hotel, Chernan Metal, Chinese Maritime, and Camellia Metal; as well as few others. The company operates under Healthcare sector and is part of Medical Instruments & Supplies industry. Analyzing Medeon Biodesign competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Medeon Biodesign to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Medeon Biodesign Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Medeon Biodesign competition on your existing holdings.
  
Hype
Prediction
LowEstimatedHigh
40.6042.5044.40
Details
Intrinsic
Valuation
LowRealHigh
40.5142.4144.31
Details
Naive
Forecast
LowNextHigh
40.3842.2744.17
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
42.1344.3046.48
Details

Medeon Biodesign Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Medeon Biodesign and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Medeon and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Medeon Biodesign does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
6146
+ 0.77
2702
2736
+ 0.6
2064
2736
+ 0.55
2702
6146
+ 0.55
3631
2736
+ 0.54
2706
2064
+ 0.41
2702
  
High negative correlations   
6183
- 0.72
3631
6146
- 0.56
6183
2612
- 0.4
3631
2736
- 0.36
3631
6183
- 0.22
2702
6146
- 0.14
2612

Risk-Adjusted Indicators

There is a big difference between Medeon Stock performing well and Medeon Biodesign Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Medeon Biodesign's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Medeon Biodesign Competitive Analysis

The better you understand Medeon Biodesign competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Medeon Biodesign's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Medeon Biodesign's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
6499 2702 2706 3631 2612 2064 6183 6146 2736
 2.63 
 42.50 
Medeon
 0.88 
 16.80 
Hotel
 0.67 
 14.80 
First
 0.24 
 41.05 
Chernan
 3.45 
 43.35 
Chinese
 0.68 
 14.50 
Camellia
 0.25 
 81.40 
Trade
 2.66 
 201.00 
Sporton
 0.27 
 18.55 
HOYA
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Very steady
Very steady
Not too volatile
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Very Weak
Very Weak
Weak
Very Weak
OK
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Quite High
Low
Low
Average
Low
Low
Low
Low
Above Average
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Over Valued
Fairly Valued
Over Valued
Fairly Valued
Fairly Valued
Fairly Valued
Over Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Sell
Sell
Cautious Hold
Strong Sell
Sell
Hold
Strong Hold
Cautious Hold
Cautious Hold
Current Ratio
N/A
3.09
17.87
N/A
1.63
1.03
3.41
3.21
N/A
Net Asset
4.36 B
8.61 B
10.44 B
2.77 B
19.08 B
3.38 B
3.88 B
6.13 B
2.29 B
Profit Margin
-1.31
1.66
0.99
-0.11
0.19
0.0575
0.22
0.3
0.061
EBITDA
(453.87 M)
115.48 M
96.85 M
11.63 M
2.1 B
229.07 M
658.93 M
1.86 B
135.44 M
Operating Margin
-1.64
0.0256
0.69
-0.38
0.21
0.0342
0.26
0.37
0.079
Current Valuation
3.37 B
5.56 B
4.36 B
3.31 B
10.04 B
2.53 B
7.77 B
19.07 B
1.55 B
Price To Book
1.29
1.19
0.75
2.36
0.59
0.97
3.72
4.68
0.94
Retained Earnings
N/A
172 M
2.6 B
N/A
8.1 B
N/A
552 M
N/A
N/A
Current Asset
N/A
1.78 B
2.37 B
N/A
5.91 B
N/A
1.34 B
N/A
N/A
Five Year Return
N/A
N/A
1.11
N/A
N/A
N/A
4.18
3.36
N/A
Beta
0.79
1.18
0.41
0.87
1.0
0.45
0.3
0.82
0.79
Number Of Employees
16
11
37
11
16
17
45
14
12
Shares Outstanding
87.64 M
149.16 M
500 M
81.82 M
197.48 M
69.33 M
150 M
97.02 M
48.99 M
Cash Flow From Operations
(293.38 M)
(81.99 M)
133.94 M
(73.46 M)
1.14 B
(316.84 M)
587.72 M
1.95 B
108.19 M
Annual Yield
0.0169
0.0441
0.0099
0.0133
0.07
0.0538
0.0333
0.0371
0.0098
Total Debt
N/A
3.68 B
N/A
726.37 M
4.62 B
N/A
8.06 M
60.54 M
472.19 M
Return On Equity
-0.1
0.0467
0.031
-0.0126
0.0727
0.11
0.22
0.33
0.0323
Z Score
N/A
N/A
N/A
2.4
0.6
N/A
N/A
N/A
1.2
Return On Asset
-0.0639
0.0024
0.0116
-0.0138
0.0293
0.016
0.12
0.18
0.0135
Book Value Per Share
43.26
19.82
19.05
16.97
60.62
17.63
16.14
48.68
23.76
Current Liabilities
N/A
1.27 B
155 M
N/A
3.98 B
N/A
388 M
N/A
N/A
Total Asset
4.36 B
8.61 B
10.44 B
2.77 B
19.08 B
3.38 B
3.88 B
6.13 B
2.29 B
Last Dividend Paid
0.83
0.74
0.14
0.5
2.68
1.0
2.05
9.0
N/A
Debt To Equity
N/A
1.9
N/A
N/A
91.4
110.3
0.3
1.5
N/A
Target Price
N/A
33.96
40.0
N/A
57.6
N/A
N/A
320.0
N/A
Shares Owned By Institutions
4.65
N/A
2.3
N/A
1.0
N/A
5.83
34.9
N/A
Market Capitalization
5 B
3.51 B
7.15 B
3.02 B
7.64 B
1.26 B
9.29 B
23.09 B
1.15 B
Price To Earning
N/A
1.61
14.85
N/A
12.65
58.33
20.35
27.08
N/A
Price To Sales
19.67
2.71
24.5
21.8
1.76
0.51
3.77
4.52
1.79
Net Income
2.08 B
1.83 B
78.4 M
(13.31 M)
1.04 B
125.64 M
425.66 M
1.07 B
(34.04 M)
Earnings Per Share
30.41
0.58
0.57
-0.094
4.14
1.95
3.4
15.19
0.74
Shares Owned By Insiders
50.07
70.1
73.39
83.4
66.69
59.09
60.24
30.21
46.71
Revenue
68.96 M
821.15 M
252.88 M
193.45 M
3.55 B
2.7 B
2.23 B
4.32 B
493.42 M
Working Capital
N/A
505 M
2.21 B
N/A
1.93 B
N/A
955 M
N/A
N/A
Cash And Equivalents
N/A
1.96 B
2.6 B
N/A
3.6 B
136.84 M
979.04 M
1.64 B
N/A
Cash Per Share
N/A
13.14
5.21
N/A
18.23
1.75
6.53
17.71
N/A
Gross Profit
28.63 M
627.73 M
194.2 M
16.59 M
774.37 M
285.83 M
907.02 M
2.16 B
254.42 M
Day Typical Price
42.88
16.83
14.83
40.98
43.88
14.65
81.47
202.67
18.65
Accumulation Distribution
0.0263
0.0118
0.0067
0.0289
0.0421
0.0301
0.0122
0.0291
0.0159
Market Facilitation Index
1.15
0.2
0.1
1.2
1.9
0.45
1.0
6.0
0.3
Daily Balance Of Power
(1.00)
(0.75)
(1.00)
(0.08)
(0.82)
(0.22)
(0.20)
(0.92)
(0.17)
Period Momentum Indicator
(1.15)
(0.15)
(0.10)
(0.10)
(1.55)
(0.10)
(0.20)
(5.50)
(0.05)
Rate Of Daily Change
0.97
0.99
0.99
1.0
0.97
0.99
1.0
0.97
1.0
Day Median Price
43.08
16.85
14.85
40.95
44.15
14.73
81.5
203.5
18.7
Price Action Indicator
(1.15)
(0.12)
(0.10)
0.05
(1.57)
(0.27)
(0.20)
(5.25)
(0.18)
Coefficient Of Variation
(3,033)
(714.30)
(1,464)
(2,418)
4591.53
(5,460)
693.53
(850.21)
(2,098)
Mean Deviation
1.11
0.5388
0.4236
1.35
1.13
1.09
0.738
0.9436
0.9735
Jensen Alpha
(0.08)
(0.13)
(0.06)
(0.07)
0.0042
(0.09)
0.0959
(0.19)
(0.11)
Total Risk Alpha
(0.36)
(0.25)
(0.15)
(0.41)
(0.23)
(0.32)
(0.02)
(0.36)
(0.33)
Sortino Ratio
N/A
N/A
N/A
N/A
(0.05)
N/A
0.0183
N/A
N/A
Downside Variance
N/A
N/A
N/A
N/A
2.9
N/A
1.07
N/A
N/A
Standard Deviation
1.9
0.8125
0.6349
2.1
1.7
1.86
1.0
1.3
1.64
Kurtosis
13.01
9.32
3.74
2.45
3.01
12.01
0.2157
0.9812
10.34
Potential Upside
2.55
1.15
0.9934
4.3
2.3
1.75
1.86
1.89
1.93
Treynor Ratio
(1.07)
(3.88)
(1.07)
0.4532
0.1369
(0.12)
0.4039
(0.79)
(0.45)
Maximum Drawdown
12.48
4.23
2.96
12.63
9.2
15.19
4.77
6.04
12.65
Variance
3.59
0.6602
0.4031
4.4
2.88
3.44
1.0
1.68
2.68
Market Risk Adjusted Performance
(1.06)
(3.87)
(1.06)
0.4632
0.1469
(0.11)
0.4139
(0.78)
(0.44)
Risk Adjusted Performance
(0.02)
(0.11)
(0.05)
(0.03)
0.0222
(0.01)
0.1128
(0.09)
(0.03)
Skewness
2.94
(1.70)
(1.38)
0.0477
0.7473
(1.83)
0.0247
(0.15)
1.31
Semi Deviation
N/A
N/A
N/A
N/A
1.44
N/A
0.7407
N/A
N/A
Information Ratio
(0.1)
(0.29)
(0.27)
(0.10)
(0.05)
(0.09)
0.0189
(0.21)
(0.12)
Value At Risk
(1.93)
(1.10)
(1.00)
(3.33)
(2.76)
(2.48)
(1.69)
(2.14)
(2.16)
Expected Short fall
N/A
N/A
N/A
N/A
(1.37)
N/A
(0.86)
N/A
N/A
Downside Deviation
N/A
N/A
N/A
N/A
1.7
N/A
1.03
N/A
N/A
Semi Variance
N/A
N/A
N/A
N/A
2.07
N/A
0.5486
N/A
N/A

Medeon Biodesign Competition Performance Charts

Five steps to successful analysis of Medeon Biodesign Competition

Medeon Biodesign's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Medeon Biodesign in relation to its competition. Medeon Biodesign's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Medeon Biodesign in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Medeon Biodesign's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Medeon Biodesign, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Medeon Biodesign position

In addition to having Medeon Biodesign in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Driverless Cars Thematic Idea Now

Driverless Cars
Driverless Cars Theme
It encompasses large technology companies, automotive makers, security firms, and thematic ETFs across multiple industries. These entities are directly or indirectly involved in shaping the development and marketing of self-driving vehicles. The Driverless Cars theme has 36 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Driverless Cars Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Medeon Stock Analysis

When running Medeon Biodesign's price analysis, check to measure Medeon Biodesign's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medeon Biodesign is operating at the current time. Most of Medeon Biodesign's value examination focuses on studying past and present price action to predict the probability of Medeon Biodesign's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medeon Biodesign's price. Additionally, you may evaluate how the addition of Medeon Biodesign to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY